Type 2 Diabetes
Showing NaN - NaN of 55
Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Retatrutide
- Placebo
-
Los Angeles, California
- +91 more
Jul 10, 2023
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)
Not yet recruiting
- Type 2 Diabetes
- Tirzepatide
- Antihyperglycemic medication
-
Birmingham, Alabama
- +96 more
Aug 8, 2022
Type 2 Diabetes Trial in Atlanta (Educational Video about SCB, Survey on child feeding and related knowledge and practices,
Recruiting
- Type 2 Diabetes
- Educational Video about SCB
- +2 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta - Hughes Spalding Hospital
May 31, 2022
Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- +2 more
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +74 more
Apr 18, 2022
End-Stage Renal Disease, Type 2 Diabetes Trial in Atlanta (Dexcom real-time G6 Continuous Glucose Monitoring System (CGM), POC
Recruiting
- End-Stage Renal Disease
- Type 2 Diabetes
- Dexcom real-time G6 Continuous Glucose Monitoring System (CGM)
- POC BG
-
Atlanta, Georgia
- +1 more
Feb 18, 2022
Type 2 Diabetes Trial in United States (BT-001, Physician-guided Standard of Care for type 2 diabetes)
Active, not recruiting
- Type 2 Diabetes
- BT-001
- Physician-guided Standard of Care for type 2 diabetes
-
San Francisco, California
- +5 more
Jan 13, 2022
Type 2 Diabetes Trial in Miami, Atlanta, New York (Liraglutide + OADs, Glargine + OADs)
Completed
- Type 2 Diabetes
- Liraglutide + OADs
- Glargine + OADs
-
Miami, Florida
- +4 more
Oct 5, 2021
Type 2 Diabetes Trial in Atlanta (Plant-based diet with no oxysterols, Standard ADA Diet (SADA))
Recruiting
- Type 2 Diabetes
- Plant-based diet with no oxysterols
- Standard ADA Diet (SADA)
-
Atlanta, GeorgiaMorehouse School of Medicine
Oct 8, 2021
Type 2 Diabetes, PreDiabetes Trial in Atlanta (NDPP + Basketball (BB), NDPP Standard of Care SOC)
Enrolling by invitation
- Type 2 Diabetes
- PreDiabetes
- NDPP + Basketball (BB)
- NDPP Standard of Care SOC
-
Atlanta, GeorgiaKaiser Permanente Georgia, Center for Research and Evaluation
Sep 24, 2021
TODAY Genetics Study
Completed
- Type 2 Diabetes
-
Little Rock, Arkansas
- +24 more
Jul 28, 2021
Type 1 Diabetes, Type 2 Diabetes Trial in Aurora, Atlanta (Guardian Sensor (3))
Completed
- Type 1 Diabetes
- Type 2 Diabetes
- Guardian Sensor (3)
-
Aurora, Colorado
- +1 more
Aug 28, 2020
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Type 2 Diabetes Trial in United States (Salsalate, Placebo)
Type 2 Diabetes Trial in United States (ITCA 650 (exenatide in DUROS))
Terminated
- Type 2 Diabetes
- ITCA 650 (exenatide in DUROS)
-
Birmingham, Alabama
- +50 more
Mar 4, 2019
Type 2 Diabetes, Hyperglycemia Trial in United States (sliding scale regular insulin (SSRI), Basal Bolus, Basal Plus)
Completed
- Type 2 Diabetes
- Hyperglycemia
- sliding scale regular insulin (SSRI)
- +2 more
-
Atlanta, Georgia
- +4 more
Sep 14, 2018
Type 2 Diabetes Trial in United States (Insulin Pump therapy)
Completed
- Type 2 Diabetes
- Insulin Pump therapy
-
La Jolla, California
- +5 more
Sep 20, 2017
Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin
Completed
- Type 2 Diabetes
- Insulin glargine/lixisenatide (HOE901/AVE0010)
- +2 more
-
Birmingham, Alabama
- +235 more
Mar 31, 2017
Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide Fixed Ratio Combination, Insulin glargine (HOE901),
Completed
- Type 2 Diabetes
- Insulin glargine/lixisenatide Fixed Ratio Combination
- +3 more
-
Phoenix, Arizona
- +272 more
Mar 31, 2017
Type 1 Diabetes, Type 2 Diabetes Trial in Atlanta (Regular Insulin, Humalog)
Withdrawn
- Type 1 Diabetes
- Type 2 Diabetes
- Regular Insulin
- Humalog
-
Atlanta, GeorgiaEmory Healthcare Ambulatory Surgical Center
Mar 13, 2017
Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)
Terminated
- Type 2 Diabetes
- Obesity
- EndoBarrier
- Sham Procedure
-
Birmingham, Alabama
- +24 more
Dec 2, 2016